Where To Now For Toshiba?
This article was originally published in Clinica
If 2015 was the worst year in the history of Toshiba Corp – with senior heads rolling, share prices tumbling and the first half-year loss for many a year in the wake of an accounting scandal in which the group had artificially inflated its profits by ¥155bn ($1.33bn) over a seven-year period – 2016 does not look to be shaping up too well either.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.